4.8 Article

Mucosal and systemic immune responses after a single intranasal dose of nanoparticle and spore-based subunit vaccines in mice with pre-existing lung mycobacterial immunity

Related references

Note: Only part of the references are listed.
Review Biochemistry & Molecular Biology

Nasal vaccines: solutions for respiratory infectious diseases

Rika Nakahashi-Ouchida et al.

Summary: Nasal vaccines induce dual protective immunity against pathogens at mucosal surfaces and systemically, offering potential for preventing respiratory infections like COVID-19. However, safety concerns arise due to the proximity of the nasal cavity to the central nervous system (CNS). This review provides an overview of current efforts in developing safe and effective nasal vaccines and delivery systems, along with their clinical applications and safety evaluation.

TRENDS IN MOLECULAR MEDICINE (2023)

Article Microbiology

Airway T cells are a correlate of i.v. Bacille Calmette-Guerin-mediated protection against tuberculosis in rhesus macaques

Patricia A. Darrah et al.

Summary: Recent research shows that intravenous administration of BCG vaccine provides better protection against tuberculosis. A dose-ranging study in macaques reveals that CD4 T cell immunity and NK cells in the bronchoalveolar lavage (BAL) correlate with protection.

CELL HOST & MICROBE (2023)

Review Immunology

Advances in intranasal vaccine delivery: A promising non-invasive route of immunization

Eleni Kehagia et al.

Summary: The importance of vaccination has been proven, especially in the prevention of infections such as SARS-COV-2. Parenteral vaccination is the most common method, while nasal vaccines offer the advantage of activating immune cells in the respiratory tract. The development of nanoparticulate systems has shown promise in formulating nasal vaccines for long-lasting immunity.

VACCINE (2023)

Article Multidisciplinary Sciences

Promising tuberculosis vaccine gets US$550-million shot in the arm

Lilly Tozer

NATURE (2023)

Article Immunology

Spore-FP1 tuberculosis mucosal vaccine candidate is highly protective in guinea pigs but fails to improve on BCG-conferred protection in non-human primates

Andrew D. White et al.

Summary: This study focuses on the vaccine for tuberculosis and finds that the Spore-FP1 mucosal vaccine candidate can provide certain protection in guinea pigs and rhesus macaques. Although this vaccine can elicit higher immune responses compared to the BCG vaccine, it does not significantly improve disease pathology and bacterial burden.

FRONTIERS IN IMMUNOLOGY (2023)

Review Immunology

Tissue resident memory T cells in the respiratory tract

Ming Z. M. Zheng et al.

Summary: Tissue-resident memory (Trm) cells in the respiratory tract play a crucial role in local immune responses against infections. Factors influencing the development, longevity, and immune surveillance of Trm cells were discussed, along with vaccination regimes harnessing these cells as new strategies to combat future global pandemics.

MUCOSAL IMMUNOLOGY (2022)

Article Medicine, Research & Experimental

Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory- mucosal immunity in humans

Mangalakumari Jeyanathan et al.

Summary: Inhaled aerosol delivery of Ad-vectored vaccines is safe and effective in inducing respiratory mucosal immunity. This study provides evidence for the development of aerosol vaccine strategies against respiratory pathogens.

JCI INSIGHT (2022)

Article Immunology

Multimodal profiling of lung granulomas in macaques reveals cellular correlates of tuberculosis control

Hannah P. Gideon et al.

Summary: This study focuses on tuberculosis lung infection and its complex multicellular structure, the granuloma. Through various techniques, the study identifies factors that influence bacterial control in granulomas. It shows that granulomas with bacterial persistence are enriched with different cell types that communicate through immune and wound-healing pathways. On the other hand, granulomas that drive bacterial control are characterized by diverse cell populations engaged in pro-inflammatory signaling networks. The study also finds that granulomas that arise later in infection display characteristics of restrictive granulomas and are more effective at killing Mycobacterium tuberculosis.

IMMUNITY (2022)

Article Microbiology

Listeria-Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice

Qingmei Jia et al.

Summary: This study presents a new tuberculosis vaccine that utilizes an attenuated strain of Listeria monocytogenes as a vector and expresses multiple immunologically protective proteins of Mycobacterium tuberculosis. In mouse models, this vaccine enhances the protective efficacy of existing tuberculosis vaccines. It holds promise as a new option to combat the tuberculosis pandemic.
Review Microbiology

Immune evasion and provocation by Mycobacterium tuberculosis

Pallavi Chandra et al.

Summary: In this Review, the authors discuss the strategies used by Mycobacterium tuberculosis to evade the immune response and exploit the host inflammatory response during different phases of its life cycle. They highlight recent studies, identify gaps in knowledge and emphasize the importance of a detailed molecular understanding for the development of novel therapies, vaccines and diagnostics.

NATURE REVIEWS MICROBIOLOGY (2022)

Article Microbiology

The immune landscape in tuberculosis reveals populations linked to disease and latency

Ekaterina Esaulova et al.

Summary: The immune landscape of the lungs in NHPs with LTBI and PTB was characterized using high-throughput technologies. PTB in macaque lungs is characterized by the influx of pDCs, an IFN-responsive macrophage population, and activated T cell responses. On the other hand, LTBI in macaques is marked by the accumulation of a CD27(+) NK cell subset in the lungs.

CELL HOST & MICROBE (2021)

Article Multidisciplinary Sciences

Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis

Avia Watson et al.

Summary: This study reveals inhibitory B cell responses targeting PstS1 during active tuberculosis, and characterizes distinct interaction modes of human anti-Mycobacteria antibodies in crystal structures that mediate protection in vitro.

NATURE COMMUNICATIONS (2021)

Article Multidisciplinary Sciences

A Mycobacterium tuberculosis-specific subunit vaccine that provides synergistic immunity upon co-administration with Bacillus Calmette-Guerin

Joshua S. Woodworth et al.

Summary: This study aims to design a TB subunit vaccine composed of antigens not shared with BCG and explore the advantages of this design in a BCG + subunit co-administration vaccine strategy. H107, an Mtb-specific subunit vaccine, shows no crossreactivity with BCG and does not inhibit BCG colonization, but instead leads to increased adaptive responses against both H107 and BCG when co-administered with BCG, broadening the overall vaccine repertoire.

NATURE COMMUNICATIONS (2021)

Article Immunology

Pulmonary BCG induces lung-resident macrophage activation and confers long-term protection against tuberculosis

Elena Mata et al.

Summary: In this study, pulmonary delivery of BCG was shown to preactivate alveolar macrophages, leading to efficient containment of Mtb and potential protection against respiratory pathogens. The results suggest the generation of a trained innate memory-like response in alveolar macrophages induced by pulmonary BCG vaccination, even after vaccine clearance. Additionally, BCG-induced innate activation also provided heterologous protection against Streptococcus pneumoniae challenge.

SCIENCE IMMUNOLOGY (2021)

Article Immunology

Genetic models of latent tuberculosis in mice reveal differential influence of adaptive immunity

Hongwei Su et al.

Summary: By transiently depleting biotin protein ligase and thioredoxin reductase, mouse models of latent Mycobacterium tuberculosis infection have been established. These models show different patterns of latent infection, with one requiring adaptive immunity for control and having a high relapse frequency, while the other is independent of adaptive immunity and has low relapse rates.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Review Microbiology

Clinical Development of New TB Vaccines: Recent Advances and Next Steps

Mark Hatherill et al.

FRONTIERS IN MICROBIOLOGY (2020)

Article Immunology

Mucosal Therapy of Multi-Drug Resistant Tuberculosis With IgA and Interferon-γ

Andy C. Tran et al.

FRONTIERS IN IMMUNOLOGY (2020)

Review Immunology

Mucosal delivery of tuberculosis vaccines: a review of current approaches and challenges

Elena Stylianou et al.

EXPERT REVIEW OF VACCINES (2019)

Article Biochemistry & Molecular Biology

Prevention of tuberculosis infection and disease by local BCG in repeatedly exposed rhesus macaques

Karin Dijkman et al.

NATURE MEDICINE (2019)

Review Immunology

Emerging Themes for the Role of Antibodies in Tuberculosis

Andy C. Tran et al.

IMMUNE NETWORK (2019)

Review Immunology

Moving tuberculosis vaccines from theory to practice

Peter Andersen et al.

NATURE REVIEWS IMMUNOLOGY (2019)

Article Biotechnology & Applied Microbiology

Nanoparticle-Fusion Protein Complexes Protect against Mycobacterium tuberculosis Infection

Peter Hart et al.

MOLECULAR THERAPY (2018)

Review Pharmacology & Pharmacy

Poly(I:C) as cancer vaccine adjuvant: Knocking on the door of medical breakthroughs

Rachid Ammi et al.

PHARMACOLOGY & THERAPEUTICS (2015)

Review Immunology

Harnessing local and systemic immunity for vaccines against tuberculosis

P. C. L. Beverley et al.

MUCOSAL IMMUNOLOGY (2014)

Review Pharmacology & Pharmacy

Particulate formulations for the delivery of poly(I:C) as vaccine adjuvant

Annina M. Hafner et al.

ADVANCED DRUG DELIVERY REVIEWS (2013)

Article Infectious Diseases

Immunogenicity of dormancy-related antigens in individuals infected with Mycobacterium tuberculosis in Japan

H. Hozumi et al.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2013)

Article Biochemistry & Molecular Biology

A multistage tuberculosis vaccine that confers efficient protection before and after exposure

Claus Aagaard et al.

NATURE MEDICINE (2011)

Article Respiratory System

Response to Rv2628 latency antigen associates with cured tuberculosis and remote infection

D. Goletti et al.

EUROPEAN RESPIRATORY JOURNAL (2010)

Review Immunology

T cells in mycobacterial infection and disease

Andrea M. Cooper

CURRENT OPINION IN IMMUNOLOGY (2009)